Inovio Pharmaceuticals Inc. closed 88.27% short of its 52-week high of $14.75, which the company reached on April 1st.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” ...

INOVIO (NASDAQ: INO) released its financial results and operational highlights for 2024, marking significant strides in its ...

Inovio Pharmaceuticals Inc (INO) addresses manufacturing issues and progresses towards BLA submission, despite financial ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

Rachael Hewer directs a vibrant production featuring Giselle Allen as Senta and Jordan Shanahan as the Dutchman ...

INO-3107 works by inducing T cell responses against HPV-6 and HPV-11, the viruses responsible for RRP, and has shown ...

International Business Times unpacks INO Armor's founding, which was shaped by a near-fatal tragic event, and explores the ...

Pre-earnings options volume in Inovio (INO) is normal with calls leading puts 19:6. Implied volatility suggests the market is anticipating a ...

Citizens JMP lowered the firm’s price target on Inovio (INO) to $12 from $18 and keeps an Outperform rating on the shares. Inovio expressed ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

Shares of Inovio Pharmaceuticals Inc. INO slid 3.72% to $1.81 Tuesday, on what proved to be an all-around positive trading ...